A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Article Published on 2023-01-312023-07-11 Journal: Cell Reports [Category] [DOI] 10.1016/j.celrep.2022.111903 PMC 바로가기
On the evolution of SARS-CoV-2 and the emergence of variants of concernArticle Published on 2023-01-012023-07-10 Journal: Trends in microbiology [Category] [DOI] 10.1016/j.tim.2022.10.008 PMC 바로가기
SARS-CoV-2 evolves to reduce but not abolish neutralizing actionArticle Published on 2023-01-012023-07-10 Journal: Journal of medical virology [Category] [DOI] 10.1002/jmv.28207 PMC 바로가기
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective글로벌 관점에서 COVID-19 백신 부스터의 물류 판단Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] [DOI] 10.1080/21645515.2021.2020572 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated IndividualsArticle Published on 2022-12-292023-07-11 Journal: Viruses [Category] [DOI] 10.3390/v15010101 PMC 바로가기
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2DArticle Published on 2022-12-272023-07-11 Journal: Cell Reports [Category] [DOI] 10.1016/j.celrep.2022.111892 PMC 바로가기
Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters시리아 골든 햄스터에서 SARS-CoV-2 Omicron BA.1(B.1.1.529) 변종 접종 후 폐 병변Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2095932 PMC 바로가기 [Article Type] Article
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infectionDelta 및 Omicron SARS-CoV-2 감염에 대한 동종 및 이종 BNT162b2, CoronaVac 및 AZD1222 추가 백신 접종의 실제 효과Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2072773 PMC 바로가기 [Article Type] Article
Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants코로나바이러스 질병 재조합 소단위 백신의 세 번째 용량으로 이종 부스팅은 다양한 중증 급성 호흡기 증후군 코로나바이러스 2 변이체에 대한 중화 항체 및 T 세포 면역을 증가시킵니다Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2048969 PMC 바로가기 [Article Type] Article
Research progress on vaccine efficacy against SARS-CoV-2 variants of concern우려되는 SARS-CoV-2 변이체에 대한 백신 효능 연구 진행Review Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] [DOI] 10.1080/21645515.2022.2057161 PMC 바로가기 [Article Type] Review